Haemonetics Corporation (HAE)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 02:58PM EDT. Market open.
| Previous close | 87.66 |
| Open | 87.49 |
| Bid | 89.95 x 900 |
| Ask | 90.09 x 1000 |
| Day's range | 87.75 - 90.20 |
| 52-week range | 70.74 - 95.26 |
| Volume | |
| Avg. volume | 487,283 |
| Market cap | 4.57B |
| Beta (5Y monthly) | 0.36 |
| PE ratio (TTM) | 36.58 |
| EPS (TTM) | 2.46 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 105.57 |
Simply Wall St.Is Haemonetics Corporation's (NYSE:HAE) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Haemonetics' (NYSE:HAE) stock is up by a considerable 12% over the past month. Given the company's impressive...
ZacksWhy You Should Add Haemonetics (HAE) to Your Portfolio Now
Recovery within the Hospital business and the favorable prospects of the Plasma franchise raise investors' optimism for Haemonetics (HAE).
PR NewswireHaemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2024 financial results at 6:00 am ET on Thursday, May 9, 2024. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on May 9, 2024.
© 2024 Yahoo. All rights reserved.